Cyrus J. Lawrence’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-240
Closed -$20K 123
2024
Q4
$20K Sell
240
-38,212
-99% -$3.18M ﹤0.01% 153
2024
Q3
$4.58M Sell
38,452
-25,566
-40% -$3.04M 0.9% 36
2024
Q2
$9.14M Buy
64,018
+687
+1% +$98.1K 1.85% 21
2024
Q1
$8.13M Buy
+63,331
New +$8.13M 1.8% 25
2023
Q3
$5.6M Buy
+61,612
New +$5.6M 1.54% 34